Enter your mobile number below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
Getting the download link through email is temporarily not available. Please check back later.

  • Apple
  • Android
  • Windows Phone
  • Android

To get the free app, enter your mobile phone number.

Drug Discovery for Psychiatric Disorders (RSC Drug Discovery)

ISBN-13: 978-1849734943
ISBN-10: 1849734941
Why is ISBN important?
ISBN
This bar-code number lets you verify that you're getting exactly the right version or edition of a book. The 13-digit and 10-digit formats both work.
Scan an ISBN with your phone
Use the Amazon App to scan ISBNs and compare prices.
Have one to sell? Sell on Amazon
This book is not available.
Out of Print--Limited Availability.
Free Two-Day Shipping for College Students with Prime Student Free%20Two-Day%20Shipping%20for%20College%20Students%20with%20Amazon%20Student

click to open popover

Editorial Reviews

Book Description

The discovery and development of effective medicines for the treatment of psychiatric disorders is one of the great medical achievements of the past century. This unique book gives in-depth coverage of the field and provides the first point of call for those involved or interested in this rapidly expanding and increasingly fragmented field of research and drug discovery. The editors combine their wide ranging experience and extensive network of contacts with leading scientists and opinion leaders from both academia and industry to provide an authoritative reference text covering the evolution, major advances, challenges and future directions in drug discovery and medicinal chemistry for major psychiatric disorders, such as schizophrenia, depression, anxiety, ADHD, bipolar disorder, addiction and autism. --This text refers to an alternate Hardcover edition.

From the Back Cover

The discovery and development of effective medicines for the treatment of psychiatric disorders such as schizophrenia and depression has been heralded as one of the great medical achievements of the past century. Indeed, the profound impact of these medicines on our understanding of the pathophysiology underlying these diseases, the treatment of psychiatric patients and even our social perception of mental illnesses cannot be underestimated. However, there is still an urgent medical need for even more effective, safe and well-tolerated treatments. For example, currently available treatments for schizophrenia address mainly the positive symptoms and largely neglect the negative symptoms and cognitive disfunction which greatly impact overall morbidity. Similarly, whilst current first line antidepressants show significantly improved side effect profiles compared to the first generation therapies, there are still up to 40% of patients who are treatment resistant, and even in the patient population which responds well, the onset of action is slow at typically 2-3 weeks. The aim of this book is to provide the first point of call for those involved or just interested in this rapidly expanding and increasingly fragmented field of research in drug discovery. The editors have combined their wide ranging experience and extensive network of contacts with leading scientists and opinion leaders in this field to provide an authoritative reference text covering the evolution, major advances, challenges and future directions in drug discovery for major psychiatric disorders, such as schizophrenia, depression, anxiety, ADHD, bipolar disorder, addiction and autism. Written by leading experts from industry and academia the book will be essential reading for medicinal chemists, pharmacologists, and pharmaceutical scientists working in psychiatric diorders drug discovery and development. --This text refers to an alternate Hardcover edition.
NO_CONTENT_IN_FEATURE

New York Times best sellers
Browse the New York Times best sellers in popular categories like Fiction, Nonfiction, Picture Books and more. See more

Product Details

  • Series: RSC Drug Discovery
  • Hardcover: 615 pages
  • Publisher: Royal Society of Chemistry (October 8, 2012)
  • Language: English
  • ISBN-10: 1849734941
  • ISBN-13: 978-1849734943

Customer Reviews

There are no customer reviews yet.
5 star
4 star
3 star
2 star
1 star
Share your thoughts with other customers